Exosomes Engineering and Their Roles as Therapy Delivery Tools, Therapeutic Targets, and Biomarkers

被引:119
作者
Kucuk, Nika [1 ]
Primozic, Mateja [1 ]
Knez, Zeljko [1 ,2 ]
Leitgeb, Maja [1 ,2 ]
机构
[1] Univ Maribor, Fac Chem & Chem Engn, Smetanova 17, Maribor 2000, Slovenia
[2] Univ Maribor, Fac Med, Taborska Ul 8, Maribor 2000, Slovenia
关键词
exosomes; therapeutic biomaterials; cargo incorporation; therapeutic applications; drug delivery; MESENCHYMAL STEM-CELLS; EXTRACELLULAR VESICLES; CANCER-THERAPY; ORAL DELIVERY; GENE-THERAPY; NANOPARTICLES; SYSTEMS; VEHICLES; FLUID; FUNCTIONALIZATION;
D O I
10.3390/ijms22179543
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Exosomes are becoming increasingly important therapeutic biomaterials for use in a variety of therapeutic applications due to their unique characteristics, especially due to the ineffectiveness and cytotoxicity of some existing therapies and synthetic therapeutic nanocarriers. They are highly promising as carriers of drugs, genes, and other therapeutic agents that can be incorporated into their interior or onto their surface through various modification techniques to improve their targeting abilities. In addition, they are biocompatible, safe, and stable. The review focuses on different types of exosomes and methods of their preparation, including the incorporation of different kinds of cargo, especially for drug delivery purposes. In particular, their importance and effectiveness as delivery vehicles of various therapeutic agents for a variety of therapeutic applications, including different diseases and disorders such as cancer treatment, cardiovascular and neurodegenerative diseases, are emphasized. Administration routes of exosomes into the body are also included. A novelty in the article is the emphasis on global companies that are already successfully developing and testing such therapeutic biomaterials, with a focus on the most influential ones. Moreover, a comparison of the advantages and disadvantages of the various methods of exosome production is summarized for the first time.
引用
收藏
页数:37
相关论文
共 194 条
[1]
Extracellular Microvesicles as New Industrial Therapeutic Frontiers [J].
Agrahari, Vivek ;
Agrahari, Vibhuti ;
Burnouf, Pierre-Alain ;
Chew, Chee Ho ;
Burnouf, Thierry .
TRENDS IN BIOTECHNOLOGY, 2019, 37 (07) :707-729
[2]
Milk-derived exosomes for oral delivery of paclitaxel [J].
Agrawal, Ashish K. ;
Aqil, Farrukh ;
Jeyabalan, Jeyaprakash ;
Spencer, Wendy A. ;
Beck, Joshua ;
Gachuki, Beth W. ;
Alhakeem, Sara S. ;
Oben, Karine ;
Munagala, Radha ;
Bondada, Subbarao ;
Gupta, Ramesh C. .
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2017, 13 (05) :1627-1636
[3]
Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies [J].
Akers, Johnny C. ;
Gonda, David ;
Kim, Ryan ;
Carter, Bob S. ;
Chen, Clark C. .
JOURNAL OF NEURO-ONCOLOGY, 2013, 113 (01) :1-11
[4]
Naturally Occurring Exosome Vesicles as Potential Delivery Vehicle for Bioactive Compounds [J].
Akuma, Precious ;
Okagu, Ogadimma D. ;
Udenigwe, Chibuike C. .
FRONTIERS IN SUSTAINABLE FOOD SYSTEMS, 2019, 3
[5]
Preparing the Bone Tissue Regeneration Ground by Exosomes: From Diagnosis to Therapy [J].
Al-Sowayan, Batla ;
Alammari, Farah ;
Alshareeda, Alaa .
MOLECULES, 2020, 25 (18)
[6]
Mesenchymal stem cells from different sources and their derived exosomes: A pre-clinical perspective [J].
Alvarez-Viejo, Maria .
WORLD JOURNAL OF STEM CELLS, 2020, 12 (02) :100-109
[7]
Alzahrani FA, 2019, AM J TRANSL RES, V11, P2887
[8]
[Anonymous], EXOCELBIO
[9]
Exosomes and Exosome-Inspired Vesicles for Targeted Drug Delivery [J].
Antimisiaris, Sophia G. ;
Mourtas, Spyridon ;
Marazioti, Antonia .
PHARMACEUTICS, 2018, 10 (04)
[10]
Milk exosomes - Natural nanoparticles for siRNA delivery [J].
Aqil, Farrukh ;
Munagala, Radha ;
Jeyabalan, Jeyaprakash ;
Agrawal, Ashish K. ;
Kyakulaga, Al-Hassan ;
Wilcher, Sarah A. ;
Gupta, Ramesh C. .
CANCER LETTERS, 2019, 449 :186-195